ALICJA MATUSIAK: Open Payments
NPI 1174757678 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,115 in 95 payments from 13 companies in 2025. Trend: 2023 $1,634 · 2024 $1,669 · 2025 $2,115
Food & beverage: $1,892Education: $223
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 21 | $743 |
| ABBVIE INC. | 22 | $377 |
| Axsome Therapeutics, Inc. | 19 | $321 |
| Neurocrine BioSciences, Inc. | 8 | $168 |
| Otsuka America Pharmaceutical, Inc. | 7 | $146 |
| Alkermes, Inc. | 4 | $93 |
| Lundbeck LLC | 5 | $77 |
| Vanda Pharmaceuticals Inc. | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Almatica Pharma LLC | 1 | $25 |
Products named: AUSTEDO XR, VRAYLAR, Auvelity, INGREZZA, ABILIFY ASIMTUFII, REXULTI, UZEDY, ARISTADA.
Industry payments across OH — which companies pay providers there.
